Patents by Inventor Nanjing LIN

Nanjing LIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210369779
    Abstract: The present disclosure provides compositions and methods for engineered cellular compositions and methods of immunotherapy utilizing the same. Compositions of the present disclosure for immune cell regulation comprise a chimeric antigen receptor polypeptide, a T cell receptor polypeptide, and combinations thereof.
    Type: Application
    Filed: June 4, 2021
    Publication date: December 2, 2021
    Inventors: Jiaping HE, Zhe SUN, Yongliang ZHANG, Nanjing LIN, Yan HE, Xin LIU, Chao Li, Jinghua LIU, Lianjun SHEN, Pengfei JIANG, Wei CAO, Liping LIU
  • Publication number: 20200170242
    Abstract: The present invention relates to the preparation and use of a cell cryopreservation formulation convenient for clinical use. In particular, provided is a cell cryopreservation (freezing) formulation, comprising: (1) a cell; (2) a cryopreservation diluent; the cryopreservation diluent comprising: an aqueous solution of sodium chloride, protective proteins, and dimethyl sulfoxide. The invention also relates to a corresponding cell resuscitation method. The invention adopts a no-wash cryopreservation solution for preparation of a cell frozen preparation, and the cell resuscitation and dilution for clinical use can be carried out by a simple formulating operation.
    Type: Application
    Filed: May 24, 2018
    Publication date: June 4, 2020
    Applicants: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD., CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
    Inventors: Li ZHANG, Fei WANG, Jiaping HE, Nanjing LIN, Liping LIU, Xin LIU, Chao LI, Shuqian YU, Yonglai HU, Jiawei ZHAO, Zhe SUN, Xiaoyu LU